
Aditya Birla SL Pharma & Healthcare Fund (G)
Equity · Sectoral
16.48%
Last 1 year
- Exit Load
- 1.00%
- Expense Ratio
- 2.29%
- Min. AmountMin. SIP Amount
- ₹100
- Min. Lump SumMin. Lump sum
- ₹1,000
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹12,05,764
- IRR
- 18.309%
- Absolute Gain
- +₹3,05,764 (+34.0%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 16.5%
- 3Y Returns
- 18.3%
- 5Y Returns
- 14.0%
- Alpha
- 13.26
Holding Analysis
Equity/Debt/Cash Split
- Equity98.7%
- Debt0.6%
- Others0.7%
Market Cap Weightage
- Mid Cap40.3%
- Large Cap35.1%
- Small Cap24%
- Others0.6%
Sector allocation
- Healthcare98.1%
- Debt0.6%
- Materials0.6%
- Others0.7%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Torrent Pharma. | Pharmaceuticals | 8.83% |
| Sun Pharma.Inds. | Pharmaceuticals | 8.35% |
| Cipla | Pharmaceuticals | 7.1% |
| Apollo Hospitals | Healthcare | 6.6% |
| Sai Life | Pharmaceuticals | 4.54% |
| Aurobindo Pharma | Pharmaceuticals | 4.5% |
| Ajanta Pharma | Pharmaceuticals | 4.17% |
| Dr Lal Pathlabs | Healthcare | 3.9% |
| Mankind Pharma | Pharmaceuticals | 3.56% |
| Emcure Pharma | Pharmaceuticals | 3.06% |
- 8.83%
Torrent Pharma.
Pharmaceuticals
- 8.35%
Sun Pharma.Inds.
Pharmaceuticals
- 7.1%
Cipla
Pharmaceuticals
- 6.6%
Apollo Hospitals
Healthcare
- 4.54%
Sai Life
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
Aditya Birla SL Pharma & Healthcare Fund (G)
- 1 Y Return
- 16.48%
- 3 Y Return
- 18.31%
- 5 Y Return
- 14.02%
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes' objectives will be achieved.
Fund Management

Dhaval Shah
He has over 15 years of work experience in Equity Capital Markets. He has also worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- 13.26
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.61
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.88
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 15.31
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.08
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 47.77
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
Aditya Birla SL Pharma & Healthcare Fund – Regular Plan - Growth was launched 7 years ago and has delivered annualised returns (CAGR) of 19.24% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 16.48% 6.93% 3 Years 18.31% 14.57% 5 Years 14.02% 11.55% Since Inception 19.24% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of Aditya Birla SL Pharma & Healthcare Fund – Regular Plan - Growth is 2.29%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
Aditya Birla SL Pharma & Healthcare Fund is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in Aditya Birla SL Pharma & Healthcare Fund with ₹100 a month, or invest a lump sum of ₹1,000. Additional investments start at ₹1,000.
Aditya Birla SL Pharma & Healthcare Fund charges an exit load of 1% if redeemed within 30 days of investment. The exit load is deducted from the redemption amount.
No, Aditya Birla SL Pharma & Healthcare Fund has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
Aditya Birla SL Pharma & Healthcare Fund manages assets (AUM) of approximately ₹1,088 Cr.
As on 31 Oct 2026, Aditya Birla SL Pharma & Healthcare Fund holds 42 securities. These are its top 10 holdings:
Company % of portfolio Torrent Pharma. 8.83% Sun Pharma.Inds. 8.35% Cipla 7.10% Apollo Hospitals 6.60% Sai Life 4.54% Aurobindo Pharma 4.50% Ajanta Pharma 4.17% Dr Lal Pathlabs 3.90% Mankind Pharma 3.56% Emcure Pharma 3.06% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 98.12% Others 0.71% Debt 0.59% Materials 0.58% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the Aditya Birla Mutual Fund website, MF Central or CAMS. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












